Contract award · 26 Oct 2026

Ono type DX Breast Recurrence Score Test

Leeds Teaching Hospitals NHS Trust awarded “Ono type DX Breast Recurrence Score Test” to Exact Sciences UK Ltd for £338k on 26 Oct 2026.

Health & social careYorkshire and the Humber

Competition with a shortlist

Competitive procedure with a selection stage: suppliers were shortlisted before being invited to bid.

Key facts

Buyer
Leeds Teaching Hospitals NHS Trust · Body governed by public law
Value
£337,500
Procedure
Call-off from a framework agreement
Sector
Health & social care · Pathology services (CPV 85111800)
Timeline
  1. Contract date26 Oct 2026
  2. Published26 Oct 2026Published the same day

Description

Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
26 Oct 2026 Exact Sciences UK Ltd £338k

More from Leeds Teaching Hospitals NHS Trust

All contracts

More won by Exact Sciences UK Ltd

All contracts

Recent health & social care contracts

Sector overview